Detection of stimulant drugs of abuse in maternal and neonatal hair

Forensic Science, Medicine, and Pathology

Volumn 3, Issue 2, 2007, Pages 115-118

  Garcia Bournissen, Facundo ^a   Rokach, Ben ^a   Karaskov, Tatyana ^a   Gareri, Joey ^a   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cocaine; Forensic toxicology; Hair detection; Intrauterine exposure; Placental transfer

Indexed keywords

EID: 36949006483     PISSN: 1547769X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12024-007-0007-4     Document Type: Article

References (39)

1. Increasing morbidity and mortality associated with abuse of methamphetamine-United States, 1991-1994. MMWR Morb Mortal WkIy Rep 1995;44(47):882-6.
2. Banken JA. Drug abuse trends among youth in the United States. Ann NY Acad Sci 2004;1025:465-71.
3. Dickerson TJ, Janda KD. Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy. AAPS J 2005;7(3):E579-86.
4. Huestis MA, Choo RE. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int 2002;128(1-2):20-30.
5. Huestis MA, Choo RE. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int 2002;128(1-2):20-30.
6. Koren G, Chan D, Klein J, Karaskov T. Estimation of fetal exposure to drugs of abuse, environmental tobacco smoke, and ethanol. Ther Drug Monit 2002;24(1):23-5.
7. Lester BM, ElSohly M, Wright LL et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001;107(2):309-17.
8. Kuczkowski KM. The cocaine abusing parturient: a review of anesthetic considerations. Can J Anaesth 2004;51 (2): 145-54.
9. Ostrea EM Jr., Knapp DK, Tannenbaum L et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001:138(3):344-8.
10. Marques PR, Tippetts AS, Branch DG. Cocaine in the hair of mother-infant pairs: quantitative analysis and correlations with urine measures and self-report. Am J Drug Alcohol Abuse 1993; 19(2): 159-75.
11. Klein J, Chitayat D, Koren G. Hair analysis as a marker for fetal exposure to maternal smoking. N Engl J Med 1993;328(1):66-7.
12. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003;88(2):F98-00.
13. Kintz P, Kieffer I, Messer J, Mangin P. Nicotine analysis in neonates' hair for measuring gestational exposure to tobacco. J Forensic Sci 1993;38(1):119-23.
14. Graham K, Koren G, Klein J, Schneiderman J, Greenwald M. Determination of gestational cocaine exposure by hair analysis. JAMA 1989:262(23):3328-30.
15. Uematsu T, Yamada K, Matsuno H, Nakashima M. The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol. Ther Drug Monit 1991;13(2):183-7.
16. Kintz P, Tracqui A, Mangin P. Tobacco, drug and narcotic abuse during pregnancy. Evaluation of in utero exposure by analysis of hair of the neonate. Presse Med 1992;21(44):2139-41.
17. Klein J, Chitayat D, Koren G. Hair analysis as a marker for fetal exposure to maternal smoking. N Engl J Med 1993;328(1):66-7.
18. Akiyama M, Matsuo I, Shimizu H. Formation of comified cell envelope in human hair follicle development. Br J Dermatol 2002;146(6):968-76.
19. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003;88(2):F98-00.
20. Bandstra ES, Morrow CE, Anthony JC et al. Intrauterine growth of full-term infants: impact of prenatal cocaine exposure3. Pediatrics 2001;108(6):1309-19.
21. Bauer CR, Langer JC, Shankaran S et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 2005;159(9):824-34.
22. Bingol N, Fuchs M, Diaz V, Stone RK, Gromisch DS. Teratogenicity of cocaine in humans 2. J Pediatr 1987;110(1):93-6.
23. Chavez GF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies 1. JAMA 1989;262(6):795-8.
24. Chiriboga CA, Bateman DA, Brust JC, Hauser WA. Neurologic findings in neonates with intrauterine cocaine exposure 3. Pediatr Neurol 1993;9(2):115-9.
25. Frank DA, Bauchner H, Parker S et al. Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana 2. J Pediatr 1990:117(4):622-6.
26. Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review6. JAMA 2001;285(12):1613-25.
27. Koren G, Graham K, Shear H, Einarson T. Bias against the null hypothesis: the reproductive hazards of cocaine6. Lancet 1989;2(8677): 1440-2.
28. Lester BM, LaGasse LL, Seifer R. Cocaine exposure and children: the meaning of subtle effects 1. Science 1998; 282(5389):633-4.
29. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003;88(2):F98-00.
30. Klein J, Chitayat D, Koren G. Hair analysis as a marker for fetal exposure to maternal smoking. N Engl J Med 1993;328(1):66-7.
31. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse - the Canadian experience. Forensic Sci Int 2000;107(1-3):281-8.
32. Klein J, Chan D, Koren G. Neonatal hair analysis as a biomarker for in utero alcohol exposure. N Engl J Med 2002;347(25):2086.
33. Marques PR. Factors to consider when using hair as a cocaineexposure measure for mothers or newborns. NIDA Res Monogr 1996;166:183-97.
34. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003;88(2):F98-00.
35. Morishima HO, Okutomi T, Whittington RA, Cooper TB. Dose-related differences in the distribution of cocaine in the maternal-fetoplacental compartments in rats. Neurotoxicol Teratol 2000;22(6):837-44.
36. Zhou M, Song ZM, Lidow MS. Pharmacokinetics of cocaine in maternal and fetal rhesus monkeys at mid-gestation. J Pharmacol Exp Ther 2001;297(2):556-62.
37. Bailey B, Morris P, McMartin KI et al. Transplacental pharmacokinetics of cocaine and benzoylecgonine in plasma and hair of rhesus monkeys. Reprod Toxicol 1998; 12(5):517-23.
38. Simone C, Derewlany LO, Koren G. Cocaine transfer across a cocaine exposed placental cotyledon perfused in vitro. Life Sci 1995;57(12):L137-40.
39. Simone C, Derewlany LO, Oskamp M, Knie B, Koren G. Transfer of cocaine and benzoylecgonine across the perfused human placental cotyledon. Am J Obstet Gynecol 1994; 170(5 Pt 1): 1404-10.